Agenda of the webinar:
Speaker: Doctor Nuria Monserrat
Title: iPS-derived cardiac myocytes in cardiac repair
Speaker: Professor Wolframm Zimmermann
Title: Engineered Human Myocardium: from preclinical development to “first in man”
Needs assessment and expected educational outcome:
To update the scientific community about pluripotent stem cell-based approaches that may revolutionise the treatment of advanced heart failure, as well as current standard-of-care and clinical practice guidelines. Advanced heart failure lacks definitive treatment except for heart transplantation, which has well-known complications, including primary graft failure and chronic transplant vasculopathy. Therefore, new therapies need to be developed to improve the quality of life and survival of patients with advanced cardiovascular disease.
Learning objectives
After watching this webinar, participants will be able to:
- know the latest advances with iPSC technologies in cardiovascular reparative medicine;
- discuss optimal translational strategies to achieve meaningful results in clinical trials; and
- anticipate future pluripotent stem cell-based approaches in the field of cardiovascular reparative medicine.
This programme is supported by Novo Nordisk in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor.
Main Topic
Related Topic
Session information
This webinar is designed for basic, translational and clinical researchers involved in the field of cardiovascular reparative medicine and (advanced) heart failure.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
Technical settings
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).